BRPI1008983A2 - formulação farmacêutica - Google Patents

formulação farmacêutica

Info

Publication number
BRPI1008983A2
BRPI1008983A2 BRPI1008983A BRPI1008983A BRPI1008983A2 BR PI1008983 A2 BRPI1008983 A2 BR PI1008983A2 BR PI1008983 A BRPI1008983 A BR PI1008983A BR PI1008983 A BRPI1008983 A BR PI1008983A BR PI1008983 A2 BRPI1008983 A2 BR PI1008983A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
BRPI1008983A
Other languages
English (en)
Inventor
Michele Virno
Original Assignee
Advance Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Holdings Ltd filed Critical Advance Holdings Ltd
Publication of BRPI1008983A2 publication Critical patent/BRPI1008983A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BRPI1008983A 2009-03-12 2010-02-02 formulação farmacêutica BRPI1008983A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09155046 2009-03-12
PCT/EP2010/051222 WO2010102862A1 (en) 2009-03-12 2010-02-02 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid

Publications (1)

Publication Number Publication Date
BRPI1008983A2 true BRPI1008983A2 (pt) 2016-03-22

Family

ID=40549651

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008983A BRPI1008983A2 (pt) 2009-03-12 2010-02-02 formulação farmacêutica

Country Status (18)

Country Link
EP (1) EP2405892B1 (pt)
AU (1) AU2010223495B2 (pt)
BR (1) BRPI1008983A2 (pt)
CA (1) CA2752713C (pt)
CL (1) CL2011002225A1 (pt)
CY (1) CY1114036T1 (pt)
DK (1) DK2405892T3 (pt)
EA (1) EA019992B1 (pt)
ES (1) ES2403380T3 (pt)
HR (1) HRP20130304T1 (pt)
IL (1) IL214676A (pt)
MX (1) MX2011009509A (pt)
NZ (1) NZ594646A (pt)
PL (1) PL2405892T3 (pt)
PT (1) PT2405892E (pt)
SI (1) SI2405892T1 (pt)
SM (1) SMT201300035B (pt)
WO (1) WO2010102862A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116637069B (zh) * 2023-07-19 2023-09-19 成都金瑞基业生物科技有限公司 一种和厚朴酚脂质体透皮凝胶剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (pt) * 1982-10-07 1986-05-15
DE19536244A1 (de) 1994-09-30 1996-04-04 Juergen Dr Regenold Pharmazeutische Zusammensetzung zur lokalen Applikation
IT1270678B (it) 1994-10-20 1997-05-07 Bayer Ag Liposomi al chetoprofen
US5654337A (en) 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
IT1277430B1 (it) * 1995-08-03 1997-11-10 Bayer Italia Spa Preparazioni farmaceutiche per uso topico a base di ketoprofene
US5902110A (en) 1995-12-18 1999-05-11 The Block Drug Company Bone regeneration
US5885597A (en) 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
US6083996A (en) 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
EP2405892B1 (en) 2013-01-16
CY1114036T1 (el) 2016-07-27
SMT201300035B (it) 2013-07-09
EA201171124A1 (ru) 2012-02-28
EA019992B1 (ru) 2014-07-30
PL2405892T3 (pl) 2013-10-31
SI2405892T1 (sl) 2013-06-28
CA2752713C (en) 2017-01-03
AU2010223495A1 (en) 2011-09-08
WO2010102862A1 (en) 2010-09-16
HRP20130304T1 (en) 2013-05-31
DK2405892T3 (da) 2013-04-08
IL214676A (en) 2014-09-30
NZ594646A (en) 2013-12-20
PT2405892E (pt) 2013-04-15
AU2010223495B2 (en) 2014-12-18
CL2011002225A1 (es) 2012-07-13
MX2011009509A (es) 2012-01-20
EP2405892A1 (en) 2012-01-18
CA2752713A1 (en) 2010-09-16
ES2403380T3 (es) 2013-05-17
IL214676A0 (en) 2011-09-27

Similar Documents

Publication Publication Date Title
SMT201400069B (it) Formulazione farmaceutica
SMT201700008B (it) Composizione farmaceutica
SMT201600350B (it) Composizioni farmaceutiche
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI1004940A2 (pt) composição farmacêutica
IL245328A0 (en) Pharmaceutical composition
DK3061445T3 (da) Højkoncentrerede farmaceutiske formuleringer
BRPI1012539A2 (pt) composições farmacêuticas
SMT201700095B (is) Composizioni farmaceutiche per inalazione
EP2451274A4 (en) Pharmaceutical compositions
IT1394860B1 (it) Composti farmaceutici
BRPI0920521A2 (pt) combinação farmacêutica
BRPI1015939A2 (pt) composição farmacêutica
BRPI1009465A2 (pt) Formulação
GT201200303A (es) Formulaciones farmacéuticas
DK2654736T3 (da) Hidtil ukendt farmaceutisk sammensætning
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
EE201300005A (et) Ravimkoostis
BRPI0921654A2 (pt) formulação farmacêutica
IT1394400B1 (it) Composizioni farmaceutiche
BRPI0922653A2 (pt) preparação farmacêutica
BR112013000356A2 (pt) formulação farmacêutica injetável de malfalano
CO6801722A2 (es) Composiciones farmacéuticas
IT1393930B1 (it) Composti farmaceutici
BR112013008074A2 (pt) combinações farmacêuticas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2370 DE 07-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25B Requested transfer of rights rejected

Owner name: ADVANCE HOLDINGS LIMITED (IT)